Vancouver, Jan. 02, 2024 (GLOBE NEWSWIRE) -- The global medical foods market size was USD 22.40 Billion in 2022 and is expected to register a rapid revenue CAGR of 4.8% during the forecast period. The global medical foods market is experiencing robust growth, fueled by the increasing prevalence of chronic diseases, a surging demand for personalized nutrition, and growing awareness about prebiotics and probiotic products. Medical foods are gaining traction as healthcare providers and patients recognize the pivotal role of diet in managing symptoms of various disorders, leading to a rising demand for specialized medical food tailored to specific conditions.
One notable trend is the demand for diabetic medical food, exemplified by Nestle's Glucerna products designed to manage blood sugar levels effectively, reducing the reliance on medication and averting complications. Customized nutritional solutions are emerging as viable alternatives to pharmaceuticals, complementing traditional medical therapies.
Probiotics, crucial for a healthy microbiota and enhanced metabolic processes, are gaining popularity. Danone's introduction of Almimama, a science-based probiotic supplement for breastfeeding mothers, reflects the global trend of increased sales and product launches in the prebiotic and probiotic market.
However, the market faces challenges such as limited awareness about medical foods, availability issues in developing countries, stringent product approval regulations, high costs, and limited reimbursement coverage. Regulatory barriers often impede the launch of new products, demanding significant time and resources from companies.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2644
Route of Administration Insights:
In 2022, the oral segment dominated the global medical foods market, capturing the largest revenue share. The preference for oral administration is driven by cost-effectiveness, ease of integration into personalized medications, and quicker time-to-market facilitated by well-established technologies and quality control measures. Oral medical foods, available in various forms, including pre-thickened products and pills, present an appealing solution for healthcare facilities aiming to optimize resources.
The enteral segment is expected to experience moderate revenue growth, particularly driven by the increasing prevalence of cardiovascular and chronic diseases that make oral food consumption challenging. Technological advancements in enteral feeding devices contribute to the segment's growth.
Product Insights:
The powder segment is projected to hold a significant revenue share in the global medical foods market. Powder formulations, recommended by physicians for patients of all ages, offer commercial availability and ease of administration through oral and enteral routes. For instance, Danone's Souvenaid, a powder medical nutrition drink, addresses memory function in the early stages of Alzheimer's disease.
The liquid segment is anticipated to register steady growth, especially in pediatric and geriatric demographics, driven by increasing acceptance in cases where solid formulations are impractical or limited. Rising awareness about the benefits of liquid-formulated foods in maintaining hydration and electrolyte balance contributes to the segment's growth.
Distribution Channel Insights:
Institutional sales are poised to exhibit the fastest revenue growth in the global medical foods market. The surge is attributed to the rising number of patient visits to healthcare facilities for chronic disease management, resulting in doctors prescribing medical foods for specific conditions. The online sales segment is expected to capture the largest revenue share, driven by increasing online purchases of medical foods and the additional use of these products for long-term nutrition management.
Regional Insights:
North America led the global medical foods market in 2022, propelled by the presence of international companies and increasing prevalence of chronic diseases. Europe followed closely, driven by consumer awareness and supportive regulatory frameworks. The Asia Pacific region is anticipated to account for a substantial revenue share due to rising development, urbanization, and the prevalence of lifestyle diseases associated with modernization.
The global medical foods market is witnessing dynamic growth trends, propelled by a convergence of factors that highlight the vital role of nutrition in disease management. As the market continues to evolve, key players are focusing on innovation and regulatory compliance to meet the growing demand for personalized and specialized nutritional solutions.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2644
Scope of Research
| Report Details | Outcome |
| Market Size in 2022 | USD 22.40 Billion |
| CAGR (2023–2032) | 4.8% |
| Revenue Forecast To 2032 | USD 35.97 Billion |
| Base Year For Estimation | 2022 |
| Historical Data | 2019–2021 |
| Forecast Period | 2023–2032 |
| Quantitative Units | Revenue in USD Billion and CAGR in % from 2023 to 2032 |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered | Route of administration, product, nutritional ingredients, application, distribution channel, and region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Country Scope | U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, and Rest of Middle East & Africa |
| Key Companies Profiled | Danone SA, Abbott Laboratories, Targeted Medical Pharma, Inc., Metagenics, Nestlé SA, Reckitt Benckiser Group PLC, Medtrition Inc., Primus Pharmaceuticals, Inc., Alfasigma USA, Inc., Mead Johnson & Company, LLC, Meiji Holdings Co., Ltd., Cerecin Inc., Fresenius SE & Co. KGaA, Agilent Technologies, Inc., Swiss Medical Food DE GmbH, Victus, Inc., Otsuka Pharmaceutical Factory, Inc., Cambrooke Therapeutics, Nutrasource, and Grunbiotics |
| Customization Scope | 10 hours of free customization and expert consultation |
Major Companies and Competitive Landscape
The global fragmented, with several medium and large-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing medical foods products in the market. Some major players included in the global medical foods market report are:
- Danone SA
- Abbott Laboratories
- Targeted Medical Pharma, Inc.
- Metagenics
- Nestlé SA
- Reckitt Benckiser Group PLC
- Medtrition Inc.
- Primus Pharmaceuticals, Inc.
- Alfasigma USA, Inc.
- Mead Johnson & Company, LLC.
- Meiji Holdings Co., Ltd.
- Cerecin Inc.
- Fresenius SE & Co. KGaA
- Agilent Technologies, Inc.
- Swiss Medical Food DE GmbH
- Victus, Inc.
- Otsuka Pharmaceutical Factory, Inc.
- Cambrooke Therapeutics
- Nutrasource
- Grunbiotics
Strategic Development
- In November 2023, Nestlé announced the launch of Wyeth illuma, a science-based growing-up milk solution including HMOs (Human Milk Oligosaccharides) for early life nutrition, in mainland China. The National Health Commission of the country recently approved the use of such bioactives. Numerous scientific studies support the use of HMOs, demonstrating the value of these components in GI and immunological health, as well as newborn cognitive development.
- In August 2020, Nestle acquired IM HealthScience to diversify its medical food company. The companies are focusing on new product development in order to expand their product portfolios for various indications, which will help to maintain a strong market position.
Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2644
Segments Covered in Report
For the purpose of this report, Emergen research has segmented the global medical foods market on the basis of route of administration, product, nutritional ingredients, application, distribution channel, and region:
- Route of Administration Outlook (Revenue, USD Billion; 2019-2032)
- Oral
- Enteral
- Product Outlook (Revenue, USD Billion; 2019-2032)
- Pills
- Liquids
- Powder
- Others
- Nutritional Ingredients Outlook (Revenue, USD Billion; 2019-2032)
- Vitamins and Minerals
- Proteins
- Omega-3
- Isoflavones
- Phytosterols
- Others
- Application Outlook (Revenue, USD Billion; 2019-2032)
- Neurological & Psychological Disorders
- Metabolic Disorder
- Pain Management
- Gastrointestinal Disorders
- Ophthalmology
- Diabetes
- Cancer
- Orphan Disease
- Others
- Distribution Channel Outlook (Revenue, USD Billion; 2019-2032)
- Online Sales
- Institutional Sales
- Retail Sales
- Regional Outlook (Revenue, USD Billion; 2019–2032)
- North America
-
-
-
- U.S.
- Canada
- Mexico
-
-
-
- Europe
-
-
-
- Germany
- France
- UK
- Italy
- Spain
- Benelux
- Rest of Europe
-
-
-
- Asia Pacific
-
-
-
- China
- India
- Japan
- South Korea
- Rest of APAC
-
-
-
- Latin America
-
-
-
- Brazil
- Rest of LATAM
-
-
-
- Middle East & Africa
-
-
-
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of Middle East & Africa
-
-
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/medical-foods-market
Curated Reports You Shouldn't Miss: Dive In Now!
Ophthalmic Surgical Instruments Market, By Product (Cataract Surgery Devices, Glaucoma Surgery Devices, and Others), By End-Use (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), and By Region Forecast to 2032
Flexible Batteries for Wearable Medical Devices Market, By Application (Health Monitoring, Drug Delivery, and Others), By Device Type (Wearable Health Watches/Fitness Trackers, Blood Pressure Monitors, and Others), By Region Forecast to 2032
Blood Warmer Devices Market, By Sample Type (Blood Samples and Other Samples), By End-Use (Hospitals, Blood Banks & Transfusion Centers, and Tissue Banks), and By Region Forecast to 2032
Thawing System Market, By Type (Manual and Automated), By Sample Type (Blood, Embryo, Ovum, and Others), By End-Use (Blood Banks & Transfusion Centers, Tissue Banks, and Others), and By Region Forecast to 2032
Surgical Ablation Market, By Technology (Radiofrequency Ablation, Light/laser, Electrical, Cyroablation, Microwave, Ultrasound, and Hydromechanical Ablation, By Application, By End-use, and By Region Forecast to 2032
Blood Management and Diagnostics Market, By Technology, By Application (Oncology, Cardiovascular, Orthopedic, Gastrointestinal, Soft Tissue, Others), By End-Use (Hospitals, Ambulatory Surgical Centers) and By Region Forecast to 2032
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com/
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights
